Journal
CURRENT OPINION IN PHARMACOLOGY
Volume 24, Issue -, Pages 86-93Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2015.08.004
Keywords
-
Categories
Funding
- Agence Nationale de la recherche
- European Community's 7th Framework Program (BrainCAV) [222992]
- La Fondation pour la Recherche Medicale
- LabEx EpigenMed
- Fondation de France
- European Community's 7th Framework Program (BrainVectors) [286071]
- European Community's 7th Framework Program (ADVance) [290002]
Ask authors/readers for more resources
Canine adenovirus type 2 (CAV-2) vectors are powerful tools for fundamental and applied neurobiology due to their negligible immunogenicity, preferential transduction of neurons, widespread distribution via axonal transport, and duration of expression in the mammalian brain. CAV-2 vectors are internalized in neurons by the selective use of coxsackievirus and adenovirus receptor (CAR), which is located at the presynapse in neurons. Neuronal internalization and axonal transport is mediated by CAR, which potentiates vector biodistribution. The above characteristics, together with the similar to 30 kb cloning capacity of helper-dependent (HD) CAV-2 vectors, optimized CAV-2 vector creation, production and purification, is expanding the therapeutic and fundamental options for CNS gene transfer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available